Cargando…

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)

BACKGROUND: De novo steatosis is the main criteria for non-alcoholic fatty liver disease (NAFLD), which is becoming a clinically relevant comorbidity in HIV-infected patients. This may be due to the HIV virus itself, as well as long-term toxicities deriving from antiretroviral therapy. Therefore, HI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bischoff, Jenny, Gu, Wenyi, Schwarze-Zander, Carolynne, Boesecke, Christoph, Wasmuth, Jan-Christian, van Bremen, Kathrin, Dold, Leona, Rockstroh, Jürgen K, Trebicka, Jonel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427211/ https://www.ncbi.nlm.nih.gov/pubmed/34522873 http://dx.doi.org/10.1016/j.eclinm.2021.101116

Ejemplares similares

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)
por: Dold, Leona, et al.
Publicado: (2017)

Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?
por: Mohr, Raphael, et al.
Publicado: (2015)

Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients
por: Anadol, Evrim, et al.
Publicado: (2018)

Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis
por: Mohr, Raphael, et al.
Publicado: (2018)

Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART
por: Dold, Leona, et al.
Publicado: (2019)

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)
por: Dold, Leona, et al.
Publicado: (2015)

Impact of COVID‐19 on HIV late diagnosis in a specialized German centre
por: van Bremen, Kathrin, et al.
Publicado: (2022)

Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV
por: Dold, Leona, et al.
Publicado: (2023)

Implementation of EACS vaccination recommendations among people living with HIV
por: Breitschwerdt, Sven, et al.
Publicado: (2022)

Moderate endurance training (marathon-training) – effects on immunologic and metabolic parameters in HIV-infected patients: the 42 KM cologne project
por: Schlabe, Stefan, et al.
Publicado: (2017)

SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study)
por: van Bremen, Kathrin, et al.
Publicado: (2021)

microRNA‐200a: A stage‐dependent biomarker and predictor of steatosis and liver cell injury in human immunodeficiency virus patients
por: Austermann, Christian, et al.
Publicado: (2017)

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
por: Dold, L., et al.
Publicado: (2019)

Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2020)

Correction to: Treatment modifcation after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2021)

Rabies post-exposure prophylaxis in Germany − What are the challenges?
por: Meyerhoff, P., et al.
Publicado: (2021)

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients
por: Dold, L., et al.
Publicado: (2020)

HPV-associated anal lesions in HIV+ patients: long-term results regarding quality of life
por: Wesselmann, Paul, et al.
Publicado: (2020)

Circulating MiRNA-122 Levels Are Associated with Hepatic Necroinflammation and Portal Hypertension in HIV/HCV Coinfection
por: Jansen, Christian, et al.
Publicado: (2015)

Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy
por: Krämer, Benjamin, et al.
Publicado: (2017)

Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART
por: Musinguzi, Nicholas, et al.
Publicado: (2021)

Alterations of the NK cell pool in HIV/HCV co-infection
por: Kaczmarek, Dominik J., et al.
Publicado: (2017)

Combination antiretroviral therapy (cART)-induced hippocampal disorders: Highlights on therapeutic potential of Naringenin and Quercetin
por: Akang, Edidiong N., et al.
Publicado: (2019)

Transmission of Human Immunodeficiency Virus I Drug Resistance - a Case Report. What are the Clinical Implications?
por: Anadol, E, et al.
Publicado: (2010)

Effect of aprepitant on kynurenine to tryptophan ratio in cART treated and cART naïve adults living with HIV
por: Spitsin, Sergei, et al.
Publicado: (2021)

Environmental Factors Related to Pulmonary Tuberculosis in HIV-Infected Patients in the Combined Antiretroviral Therapy (cART) Era
por: Álvaro-Meca, Alejandro, et al.
Publicado: (2016)

Antiviral treatment of COVID-19: which role can clinical parameters play in therapy evaluation?
por: Hübner, Yannis R., et al.
Publicado: (2023)

Clinical Progression Rates by CD4 Cell Category Before and After the Initiation of Combination Antiretroviral Therapy (cART)
por: Guiguet, Marguerite, et al.
Publicado: (2008)

Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impairment of JAK-STAT signaling pathway
por: Liu, Man-Qing, et al.
Publicado: (2017)

Interactions of alcohol and combination antiretroviral (cART) drug in diabetic male Sprague Dawley rats: Hippocampal perturbations and toxicosis
por: Asouzu Johnson, Jaclyn, et al.
Publicado: (2023)

Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV
por: Valcour, Victor G., et al.
Publicado: (2015)

Portal vein thrombosis in patients with cirrhosis
por: von Köckritz, Leona, et al.
Publicado: (2017)

Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure
por: Schulz, Martin S., et al.
Publicado: (2022)

Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?
por: Krastinova, Evguenia, et al.
Publicado: (2015)

Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients
por: Chow, Wei Zhen, et al.
Publicado: (2015)

Adherence to combined Antiretroviral therapy (cART) among people living with HIV/AIDS in a Tertiary Hospital in Ilorin, Nigeria
por: Anyaike, Chukwuma, et al.
Publicado: (2019)

Liberation from Dialysis Dependence in a Patient with HIV-Associated Nephropathy (HIVAN) after Combined Antiretroviral Therapy (cART)
por: Ramoutar, Virin, et al.
Publicado: (2020)

Treatments for NAFLD: State of Art
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence
por: Vogel, M, et al.
Publicado: (2011)

Severe monkeypox-virus infection in undiagnosed advanced HIV infection
por: Boesecke, Christoph, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d23qavs0mgilvcim3o3fb7nele